The global Antibody Drug Conjugate Linker And Conjugation Technologies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Antibody Drug Conjugate Linker And Conjugation Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Drug Conjugate Linker And Conjugation Technologies.

Report Scope

The Antibody Drug Conjugate Linker And Conjugation Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody Drug Conjugate Linker And Conjugation Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antibody Drug Conjugate Linker And Conjugation Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antibody Drug Conjugate Linker And Conjugation Technologies Market Report

Report Metric	Details
Report Name	Antibody Drug Conjugate Linker And Conjugation Technologies Market
CAGR	5%
Segment by Type	Chemical Conjugation Enzymatic Conjugation
Segment by Application	Leukemia Lymphoma Breast Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Seattle Genetics Inc, Immunogen, Ambrx, Catalent Biologics, Immunomedics, Mersana Therapeutics, Sutro Biopharma, Iksuda Therapeutics, Legochem Biosciences, Linxis, Adc Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Drug Conjugate Linker And Conjugation Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antibody Drug Conjugate Linker And Conjugation Technologies Market report?

Ans: The main players in the Antibody Drug Conjugate Linker And Conjugation Technologies Market are Seattle Genetics Inc, Immunogen, Ambrx, Catalent Biologics, Immunomedics, Mersana Therapeutics, Sutro Biopharma, Iksuda Therapeutics, Legochem Biosciences, Linxis, Adc Therapeutics

What are the Application segmentation covered in the Antibody Drug Conjugate Linker And Conjugation Technologies Market report?

Ans: The Applications covered in the Antibody Drug Conjugate Linker And Conjugation Technologies Market report are Leukemia, Lymphoma, Breast Cancer, Others

What are the Type segmentation covered in the Antibody Drug Conjugate Linker And Conjugation Technologies Market report?

Ans: The Types covered in the Antibody Drug Conjugate Linker And Conjugation Technologies Market report are Chemical Conjugation, Enzymatic Conjugation

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Chemical Conjugation

1.2.3 Enzymatic Conjugation

1.3 Market by Application

1.3.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Leukemia

1.3.3 Lymphoma

1.3.4 Breast Cancer

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Perspective (2019-2030)

2.2 Antibody Drug Conjugate Linker And Conjugation Technologies Growth Trends by Region

2.2.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Antibody Drug Conjugate Linker And Conjugation Technologies Historic Market Size by Region (2019-2024)

2.2.3 Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Region (2025-2030)

2.3 Antibody Drug Conjugate Linker And Conjugation Technologies Market Dynamics

2.3.1 Antibody Drug Conjugate Linker And Conjugation Technologies Industry Trends

2.3.2 Antibody Drug Conjugate Linker And Conjugation Technologies Market Drivers

2.3.3 Antibody Drug Conjugate Linker And Conjugation Technologies Market Challenges

2.3.4 Antibody Drug Conjugate Linker And Conjugation Technologies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Revenue

3.1.1 Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Revenue (2019-2024)

3.1.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Players (2019-2024)

3.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue

3.4 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Concentration Ratio

3.4.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue in 2023

3.5 Antibody Drug Conjugate Linker And Conjugation Technologies Key Players Head office and Area Served

3.6 Key Players Antibody Drug Conjugate Linker And Conjugation Technologies Product Solution and Service

3.7 Date of Enter into Antibody Drug Conjugate Linker And Conjugation Technologies Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Antibody Drug Conjugate Linker And Conjugation Technologies Breakdown Data by Type

4.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Historic Market Size by Type (2019-2024)

4.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Type (2025-2030)

5 Antibody Drug Conjugate Linker And Conjugation Technologies Breakdown Data by Application

5.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Historic Market Size by Application (2019-2024)

5.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2019-2030)

6.2 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2019-2024)

6.4 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2019-2030)

7.2 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2019-2024)

7.4 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2019-2030)

8.2 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2019-2024)

8.4 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2019-2030)

9.2 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2019-2024)

9.4 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2019-2030)

10.2 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2019-2024)

10.4 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Seattle Genetics Inc

11.1.1 Seattle Genetics Inc Company Detail

11.1.2 Seattle Genetics Inc Business Overview

11.1.3 Seattle Genetics Inc Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.1.4 Seattle Genetics Inc Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

11.1.5 Seattle Genetics Inc Recent Development

11.2 Immunogen

11.2.1 Immunogen Company Detail

11.2.2 Immunogen Business Overview

11.2.3 Immunogen Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.2.4 Immunogen Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

11.2.5 Immunogen Recent Development

11.3 Ambrx

11.3.1 Ambrx Company Detail

11.3.2 Ambrx Business Overview

11.3.3 Ambrx Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.3.4 Ambrx Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

11.3.5 Ambrx Recent Development

11.4 Catalent Biologics

11.4.1 Catalent Biologics Company Detail

11.4.2 Catalent Biologics Business Overview

11.4.3 Catalent Biologics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.4.4 Catalent Biologics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

11.4.5 Catalent Biologics Recent Development

11.5 Immunomedics

11.5.1 Immunomedics Company Detail

11.5.2 Immunomedics Business Overview

11.5.3 Immunomedics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.5.4 Immunomedics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

11.5.5 Immunomedics Recent Development

11.6 Mersana Therapeutics

11.6.1 Mersana Therapeutics Company Detail

11.6.2 Mersana Therapeutics Business Overview

11.6.3 Mersana Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.6.4 Mersana Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

11.6.5 Mersana Therapeutics Recent Development

11.7 Sutro Biopharma

11.7.1 Sutro Biopharma Company Detail

11.7.2 Sutro Biopharma Business Overview

11.7.3 Sutro Biopharma Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.7.4 Sutro Biopharma Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

11.7.5 Sutro Biopharma Recent Development

11.8 Iksuda Therapeutics

11.8.1 Iksuda Therapeutics Company Detail

11.8.2 Iksuda Therapeutics Business Overview

11.8.3 Iksuda Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.8.4 Iksuda Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

11.8.5 Iksuda Therapeutics Recent Development

11.9 Legochem Biosciences

11.9.1 Legochem Biosciences Company Detail

11.9.2 Legochem Biosciences Business Overview

11.9.3 Legochem Biosciences Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.9.4 Legochem Biosciences Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

11.9.5 Legochem Biosciences Recent Development

11.10 Linxis

11.10.1 Linxis Company Detail

11.10.2 Linxis Business Overview

11.10.3 Linxis Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.10.4 Linxis Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

11.10.5 Linxis Recent Development

11.11 Adc Therapeutics

11.11.1 Adc Therapeutics Company Detail

11.11.2 Adc Therapeutics Business Overview

11.11.3 Adc Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.11.4 Adc Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

11.11.5 Adc Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Chemical Conjugation

Table 3. Key Players of Enzymatic Conjugation

Table 4. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region (2019-2024)

Table 8. Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region (2025-2030)

Table 10. Antibody Drug Conjugate Linker And Conjugation Technologies Market Trends

Table 11. Antibody Drug Conjugate Linker And Conjugation Technologies Market Drivers

Table 12. Antibody Drug Conjugate Linker And Conjugation Technologies Market Challenges

Table 13. Antibody Drug Conjugate Linker And Conjugation Technologies Market Restraints

Table 14. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Players (2019-2024)

Table 16. Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies as of 2023)

Table 17. Ranking of Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Antibody Drug Conjugate Linker And Conjugation Technologies Product Solution and Service

Table 21. Date of Enter into Antibody Drug Conjugate Linker And Conjugation Technologies Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Type (2019-2024)

Table 25. Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Type (2025-2030)

Table 27. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Application (2019-2024)

Table 29. Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Application (2025-2030)

Table 31. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2025-2030) & (US$ Million)

Table 46. Seattle Genetics Inc Company Detail

Table 47. Seattle Genetics Inc Business Overview

Table 48. Seattle Genetics Inc Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 49. Seattle Genetics Inc Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024) & (US$ Million)

Table 50. Seattle Genetics Inc Recent Development

Table 51. Immunogen Company Detail

Table 52. Immunogen Business Overview

Table 53. Immunogen Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 54. Immunogen Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024) & (US$ Million)

Table 55. Immunogen Recent Development

Table 56. Ambrx Company Detail

Table 57. Ambrx Business Overview

Table 58. Ambrx Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 59. Ambrx Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024) & (US$ Million)

Table 60. Ambrx Recent Development

Table 61. Catalent Biologics Company Detail

Table 62. Catalent Biologics Business Overview

Table 63. Catalent Biologics Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 64. Catalent Biologics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024) & (US$ Million)

Table 65. Catalent Biologics Recent Development

Table 66. Immunomedics Company Detail

Table 67. Immunomedics Business Overview

Table 68. Immunomedics Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 69. Immunomedics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024) & (US$ Million)

Table 70. Immunomedics Recent Development

Table 71. Mersana Therapeutics Company Detail

Table 72. Mersana Therapeutics Business Overview

Table 73. Mersana Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 74. Mersana Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024) & (US$ Million)

Table 75. Mersana Therapeutics Recent Development

Table 76. Sutro Biopharma Company Detail

Table 77. Sutro Biopharma Business Overview

Table 78. Sutro Biopharma Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 79. Sutro Biopharma Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024) & (US$ Million)

Table 80. Sutro Biopharma Recent Development

Table 81. Iksuda Therapeutics Company Detail

Table 82. Iksuda Therapeutics Business Overview

Table 83. Iksuda Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 84. Iksuda Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024) & (US$ Million)

Table 85. Iksuda Therapeutics Recent Development

Table 86. Legochem Biosciences Company Detail

Table 87. Legochem Biosciences Business Overview

Table 88. Legochem Biosciences Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 89. Legochem Biosciences Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024) & (US$ Million)

Table 90. Legochem Biosciences Recent Development

Table 91. Linxis Company Detail

Table 92. Linxis Business Overview

Table 93. Linxis Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 94. Linxis Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024) & (US$ Million)

Table 95. Linxis Recent Development

Table 96. Adc Therapeutics Company Detail

Table 97. Adc Therapeutics Business Overview

Table 98. Adc Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 99. Adc Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024) & (US$ Million)

Table 100. Adc Therapeutics Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Type: 2023 VS 2030

Figure 3. Chemical Conjugation Features

Figure 4. Enzymatic Conjugation Features

Figure 5. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Application: 2023 VS 2030

Figure 7. Leukemia Case Studies

Figure 8. Lymphoma Case Studies

Figure 9. Breast Cancer Case Studies

Figure 10. Others Case Studies

Figure 11. Antibody Drug Conjugate Linker And Conjugation Technologies Report Years Considered

Figure 12. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region: 2023 VS 2030

Figure 15. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Players in 2023

Figure 16. Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue in 2023

Figure 18. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2019-2030)

Figure 20. United States Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2019-2030)

Figure 24. Germany Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region (2019-2030)

Figure 32. China Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2019-2030)

Figure 40. Mexico Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2019-2030)

Figure 44. Turkey Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Seattle Genetics Inc Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

Figure 47. Immunogen Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

Figure 48. Ambrx Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

Figure 49. Catalent Biologics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

Figure 50. Immunomedics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

Figure 51. Mersana Therapeutics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

Figure 52. Sutro Biopharma Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

Figure 53. Iksuda Therapeutics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

Figure 54. Legochem Biosciences Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

Figure 55. Linxis Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

Figure 56. Adc Therapeutics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions